ArticleApplied microbiology and biotechnology2025
Foot-and-mouth disease virus vaccine with VP1 G-H loop substitution of the Cathay strain broadens antigen spectrum.
Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- VP1 region-based molecular characterization of foot-and-mouth disease virus serotype O from clinical cases in Haryana, India.BMC veterinary research · 2025Article
- Development of a Chimeric Vaccine Providing Protection Against the Type A ASIA/Sea-97 FMDVs in East Asia.Vaccines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Recently, serotype O foot-and-mouth disease viruses (FMDVs) belonging to four lineages (O/ME-SA/PanAsia, O/ME-SA/Ind2001, O/SEA/Mya-98, and O/Cathay) co-circulate in China, and the emergence of new variant viruses belonging to the Cathay lineage renders the existing vaccines less effective, which poses a serious threat to the livestock industries. The surface-exposed G-H loop of the VP1 structural protein of FMDV plays an important role in inducing neutralizing antibodies, generation of antigenic variants, and virus attachment. Here, we generated three recombinant FMDVs in which the G-H loops have been substituted with the corresponding sequences from the circulating strains of the PanAsia, Mya-98, and Cathay lineages based on an infectious cDNA clone of a chimeric FMDV, which carries amino acid substitutions in the leader protein and all surface proteins of FMDV O/XJ/CHA/2017. All mutant viruses exhibited a significantly improved replication capacity in BHK-21 cells and displayed relatively larger plaque morphologies compared with the parental virus. Chemically inactivated vaccines prepared from the parental virus and the mutant viruses all induced protective liquid-phase blocking ELISA (LPBE) antibodies against FMDVs in pigs after 28 days post vaccination (dpv), but only the vaccine with the substitution of the G-H loop of the Cathay strain induced protective neutralizing antibodies against the viruses of four lineages, while other vaccines exhibited excellent immunological cross-reactivity to the viruses of Ind2001, PanAsia, and Mya-98 lineages but did not for the Cathay virus at 28 dpv. Our studies indicated that the G-H loop of the Cathay virus plays a critical role in the antigenic drift of FMDV, which will provide key insights for designing porcinophilic FMDV vaccines in the future. KEY POINTS: • The swapping of the G-H loops of FMDVs notably improved replication capacity of FMDV in BHK-21 cells. • The swapping of the G-H loop of the Cathay virus obviously broadens antigenic coverage of FMDV vaccine. • The study showed that the G-H loop of the Cathay virus plays a critical role in antigenic drift of FMDV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.